These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2794937)

  • 1. Medical dissolution of gallstones by ursodeoxycholic acid: a clinical trial on 14 patients.
    Lin JT; Wang JT; Wang TH; Su CT
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):370-6. PubMed ID: 2794937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid].
    Realini S; Gonvers JJ; Arnold J; Borel GA; Bretholz A; Capitaine Y; Hofstetter JR; Bettini L; di Simone A
    Schweiz Med Wochenschr; 1983 Apr; 113(17):641-2. PubMed ID: 6867654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.
    Gleeson D; Ruppin DC; Saunders A; Murphy GM; Dowling RH
    Q J Med; 1990 Jul; 76(279):711-29. PubMed ID: 2217675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid.
    Erlinger S; Le Go A; Husson JM; Fevery J
    Hepatology; 1984; 4(2):308-14. PubMed ID: 6706305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
    Polli EE; Bianchi PA; Conte D; Sironi L
    Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
    Podda M; Zuin M; Carulli N; Ponz de Leon M; Dioguardi ML
    J Int Med Res; 1982; 10(1):59-63. PubMed ID: 7060825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
    Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
    Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
    Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diet on dissolution of gallstones by ursodeoxycholic acid, including a comparison between ultrasonography and cholecystography.
    Lefkof IR; Frenkiel PG; Lee DW; Cohen H; Bonorris GG; Gilmore CJ; Hamlin JA; Komaiko M; Resser K; Marks JW
    Mt Sinai J Med; 1986 Apr; 53(4):241-9. PubMed ID: 3014318
    [No Abstract]   [Full Text] [Related]  

  • 12. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The present status of agents for dissolving gallstones.
    Tangedahl T
    Am J Gastroenterol; 1985 Jan; 80(1):64-6. PubMed ID: 3881015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter study on the litholytic effect of ursodeoxycholic acid. 30 cases].
    Voirol M; Stalder GA; Fasel J; Séchaud R; Desbaillets LG; Kapp F; Krieg P; Aenishänslin HW; Wyss G
    Schweiz Med Wochenschr; 1983 Apr; 113(17):643-5. PubMed ID: 6346484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gallstones with chenodeoxy-and ursodeoxycholic acid; the influence of presence or absence of hyperlipidemia on gallstone dissolution.
    Kajiyama G; Maruhashi A; Mizuno T; Yamada K; Kawamoto T; Fujiyama M; Kubota S; Sasaki H; Oyamada K; Nakao S; Miyoshi A
    Hiroshima J Med Sci; 1979 Jun; 28(2):67-71. PubMed ID: 478985
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiolucent gallstone dissolution with bedtime UDCA administration.
    Conte D; Bozzani A; Sironi L; Rocca F; Camassa L; Bianchi PA
    Digestion; 1981; 22(6):302-4. PubMed ID: 7333417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
    Tint GS; Salen G; Colalillo A; Graber D; Verga D; Speck J; Shefer S
    Ann Intern Med; 1982 Sep; 97(3):351-6. PubMed ID: 7051912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.